Ophthalmic Business

Top Story

Read OSN’s Nov. 25 publication exclusives online

November 17, 2018

Imprimis quarterly loss decreases

November 16, 2018
Imprimis Pharmaceuticals reported a net loss of $2.5 million, or $0.12 per share, in the third quarter of 2018 compared with a net loss of $5.7 million, or $0.28 per…

AGTC posts quarterly income

November 16, 2018
Applied Genetic Technologies Corporation reported a net income of $1.2 million for the first quarter of its fiscal year compared with a net loss of $1.4 million in the…

BLOG: Embezzlement: It is your problem

November 15, 2018
If I said that you had an 83% chance of having a small cancer growing somewhere in your body, would you want to investigate and find out where, what kind and what you…
More Headlines »
Clinical Science

Progression to Surgery for Patients With Idiopathic Epiretinal Membranes and Good Vision

Ophthalmic Surgery, Lasers and Imaging Retina, October 2018, Volume 49 Issue 10
Patients with idiopathic epiretinal membranes (ERMs) and visual acuity of 20/40 or better are often monitored until…
More »

Assessing and Treating Diabetic Retinopathy Amid New Recommendations and Evidence

This activity is supported by an educational grant from Genentech, Inc.

Although rapid advances have been made in the treatment of diabetic macular edema (DME), particularly with the use of…
More »
Meeting News

VIDEO: Allegro updates progress of Luminate for DME

November 2, 2018
More »